The Latest Breaking News from Europe

RANGERS booked a place in the fifth European final in their history in their 150th anniversary year at Ibrox last night when they defeated an RB…

EINTRACHT FRANKFURT 1-0 WEST HAM (3-1 on aggregate): The Hammers failed to recover from Aaron Cresswell's early red card as their European campaign ended in Germany

Aptiv PLC (NYSE:APTV) reported first-quarter FY22 sales growth of 4% year-on-year to $4.18 billion, beating the consensus of $4.04 billion. Revenue rose 4% adjusted for currency exchange and commodity movements. Revenue in North America rose 7%, South America increased 24%, Europe fell 5%, and Asia increased 9%, which includes growth of 14% in…

The attack on Roe v Wade has roots in well-funded organisations whose tentacles have spread across the Atlantic, says author Sian Norris

The World Health Organization estimates that nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems during the first two years of the pandemic, more than double the current official death toll of over 6 million. Most of the deaths occurred in Southeast…

Johnny Morrissey, 62, now living in Spain, has been accused of facilitating international drug shipments from south America into Europe

Winning next month's legislative election may be a long shot for France's new hard-left alliance, but the fact President Emmanuel Macron now faces two eurosceptic opposition blocs should cause concern among France's European Union partners.

Most of the excess deaths are concentrated in southeast Asia, Europe, and the Americas, the WHO says

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders.  Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase…

The FDA has approved AstraZeneca plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKYF) Enhertu (trastuzumab deruxtecan) for adult patients with unresectable or metastatic HER2-positive breast cancer. The approval covers patients who have received a prior anti-HER2-based regimen either in the metastatic setting or in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within…

Cryptocurrency exchange giant Binance (CRYPTO: BNB) has acquired regulatory approval in France, Chief Executive Officer Changpeng Zhao said in a tweet on Wednesday. The move cements Binance’s plan to make Paris its European base.